Dr. Paul Warden-Hutton

Our Philosophy

We are a full-service, one-stop Patent & Trade Mark Attorney Firm.

At Houlihan², since 2002, our role is and has been to advise you on how to best and most appropriately protect your creativity and to turn your Intellectual Property into a valuable asset. We are here to assist in the securing and maintenance of your Intellectual Property Rights and also to assist with integrating these Rights into your business goals. As part of your team, our Patent Attorneys and Trade Mark Attorneys will work closely with you to tailor your requirements to fit your business needs. This is all done behind a backdrop of our philosophy to value² your asset in the most cost-effective way.

Our Patent Attorneys and Trade Mark Attorneys are creative thinkers and are able to provide solutions outside the square^® to any problem. We complement your team by bringing our wealth of experience in Patents, Trade Marks, Designs and other forms of Intellectual Property, with a fresh and enthusiastic approach.

Our Expertise

Our Patent Attorneys can assist you in protecting your inventions in all areas of Chemistry, Life Sciences, Biotechnology, Medical Devices, Electronics, Electrical and Mechanical Engineering, and ICT.

Our Patent Attorneys can also assist you in protecting the new Designs that you have applied to your products.

Our Trade Mark Attorneys can assist you to protect your Brand and your reputation through strategic Trade Mark protection, from filing through to negotiation and litigation.

Our Firm also specialises in protecting Designs and in Copyright issues.

We serve a broad client base including:

• Sole inventors;
• Universities/Research Institutes;
• Small, medium and large businesses;
• Government authorities/instrumentalities; and
• International corporations.

Show more +

A Director of the Firm, Paul holds a B.Biomed.Sci. majoring in Chemistry and Biochemistry. His B.Biomed.Sci.(Hons) year was his introduction to applied research, where he used biophysical and biological tools to investigate the causative gene of hereditary sex-linked anaemia in mice. Paul continued his applied research in the completion of a Ph.D. in Biophysics in which he performed spectroscopic, computational and informatic studies on the prion protein.

In 2003, Paul began his career in the Intellectual Property Profession when he joined a Japanese Patent Attorney Firm and worked in Osaka, Japan, for two years. Paul largely provided advice to non-Japanese IP Owners in relation to Japanese Patent Law and its landscape. With his physics, computational, chemical and biochemical backgrounds, Paul worked in both the Firm’s Information Technology and Life Sciences teams. Having spent this time in Japan, Paul has a working competency in Japanese.

Paul is a Registered Australian and New Zealand Patent & Trade Mark Attorney with a Masters in Intellectual Property Law. He returned to Australia in 2005 and entered the Australian Profession. Paul was admitted into the Partnership in 2014 and became a Director in 2018.

Paul’s practice includes drafting, prosecution and litigation of Engineering, Spectroscopic, Chemical, Medical Imaging, Sensor-technologies, Clean Technology, Mechanical, Computer Software, Biophysical and Material Science matters, as well as Plant Breeder Rights, before the Australian and New Zealand Patent Offices. With his background in applied research, Paul’s work covers most technology areas, including pneumatics, medical devices, chemical processing, anaesthesia/sleep monitoring devices, safety devices, building materials and business methods.

Paul also enjoys the gymnastics of Trade Marks and Designs and handles matters before both the Australian and New Zealand Trade Marks and Designs Offices.

He is a Member of the Asian Patent Attorney Association and a Fellow of The Institute of Patent and Trade Mark Attorneys of Australia. He is a Member of The Intellectual Property Society of Australia and New Zealand and The Royal Australian Chemical Institute. In addition, Paul also serves on the Asian Practice Committee of the US-Based IPO Association.

Show more +